Related Experiment Video
Updated: Jun 30, 2026

Point-of-Care Kidney and Genitourinary Ultrasound in Adults: Image Acquisition
Published on: June 21, 2024
Kidney growth in children with congenital hypothyroidism
Mehmet Bülbül1, Semra Cetinkaya, Seçil Ekşioğlu
1Department of Pediatric Nephrology, Sami Ulus Children's Hospital, Ankara, Turkey. mbbjkank@hotmail.com
Insights
Congenital hypothyroidism can impact kidney size in children. However, levothyroxine (L-thyroxine) treatment can lead to normal renal growth, even with delayed initiation or severe disease.
Area of Science:
- Pediatric Endocrinology
- Nephrology
- Developmental Biology
Background:
- Congenital hypothyroidism (CH) is a condition affecting thyroid hormone production in newborns.
- The impact of CH and its treatment on renal growth in pediatric populations remains understudied.
- Thyroid hormones play a crucial role in overall growth and development, including organogenesis.
Purpose of the Study:
- To investigate the effect of congenital hypothyroidism and levothyroxine (L-thyroxine) treatment on kidney size in children.
- To determine if delayed treatment initiation or severity of CH influences renal growth.
- To explore the relationship between thyroid hormone levels and relative kidney volume.
Main Methods:
- Prospective study including 40 children with CH and 37 healthy controls.
- Assessment of anthropometric data (height, weight) and kidney dimensions (kidney length, total kidney volume).
- Analysis of treatment parameters including age at L-thyroxine initiation and treatment duration, and correlation with kidney size and free thyroxine levels.
Main Results:
- Children with CH exhibited smaller kidney length and total kidney volume compared to controls.
- Kidney volume relative to body weight or height showed no significant difference between groups.
- A positive correlation was observed between relative kidney volume and average free thyroxine levels.
- No significant differences in kidney size were found based on age of L-thyroxine initiation or hypothyroidism severity.
Conclusions:
- Normal renal growth is achievable with timely levothyroxine (L-thyroxine) replacement therapy in children with congenital hypothyroidism.
- Considerable delays in treatment initiation or diagnosis of severe hypothyroidism do not preclude normal kidney development.
- Maintaining adequate thyroid hormone levels is crucial for optimal renal growth in pediatric patients with CH.
Abstract:
The effect of hypothyroidism on kidney size has not been studied in children. The aim of this study was to examine the role of congenital hypothyroidism and levothyroxine (L-thyroxine) treatment on renal growth. Forty children with congenital hypothyroidism and 37 healthy controls were prospectively included. The mean age of patients was 8.2+/-4.7 years. Patients had lower height and weight standard deviation scores compared with controls. The mean L-thyroxine initial age and treatment duration were 37.0 and 60.5 months, respectively. In 62.5% of patients, L-thyroxine was initiated after 6 months of age, and 60.0% of patients had severe hypothyroidism. Patients had lower kidney length and total kidney volume compared with controls (P < 0.05). No significant differences were found in kidney volume/body weight and kidney volume/ body height ratios between patients and controls (P > 0.05). Multiple regression analysis showed significant relationship between relative kidney volume and average free thyroxine level (P < 0.05). No significant differences in kidney sizes were found between patients who had L-thyroxine initiated before and after 6 months of age or between mild/moderate and severe hypothyroidism at diagnosis (P > 0.05). In conclusion, normal renal growth can be accomplished with L-thyroxine replacement despite considerable delay in treatment initiation and/or severe hypothyroidism.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Goiter
Kidney Transplant II: Surgical Procedure
Kidney Transplant I: Introduction
Chronic Kidney Disease II: Clinical Manifestations
Hypothyroidism II: Pathophysiology

